A. Chachoua

发表

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

R. Emerson, A. Heguy, S. Demaria, 2018, Nature Medicine.

Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's Sarcoma (AIDS-KS)

F. Muggia, M. Green, A. Chachoua, 1989, Investigational New Drugs.

Malignant Pleural Mesothelioma—A Current Review

H. Pass, J. Donington, A. Chachoua, 2008 .

Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer

J. Nemunaitis, R. Benner, C. Belani, 2013, Cancer biology & therapy.

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome.

D. Dieterich, A. Chachoua, J. Wernz, 1987, Annals of internal medicine.

TIA‐1+ cytotoxic large T‐cell lymphoma of the mediastinum: Case report

C. D. Wu, H. Yee, A. Chachoua, 2002, Diagnostic cytopathology.

A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer.

S. Taneja, E. Small, G. Bubley, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.

P. Elliott, H. Yee, D. Ryan, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience

H. Pass, P. Schiff, A. Chachoua, 2022, Frontiers in Oncology.

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.

A. Zeleniuch‐Jacquotte, H. Hochster, F. Muggia, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer.

N. Sanfilippo, S. Taneja, H. Lepor, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Increasing dyspnea due to an anterior mediastinal mass.

H. Pass, J. Ko, D. Nonaka, 2011, Chest.

Common Germline Mutations in a Patient With Multiple Primary Lung Cancers.

A. Moreira, A. Chachoua, J. Sabari, 2019, Clinical lung cancer.

The management of EGFR inhibitor adverse events: a case series and treatment paradigm

D. Cohen, A. Chachoua, Amelia M Wnorowski, 2012, International journal of dermatology.

P-611 Final results from a phase II study of erlotinib (TarcevaTM) monotherapy in patients with advanced non-small cell lung cancer following failure of platinum-based chemotherapy

J. Rigas, R. Perez-soler, G. Clark, 2003 .

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?

F. Muggia, A. Chachoua, D. Márquez-Medina, 2013, Clinical and Translational Oncology.

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma.

E. Zang, A. Chachoua, J. Wernz, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New antiviral compounds and impact in management of neoplastic disease and AIDS

Michael D. Green, A. Chachoua, 1987 .

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

H. Hochster, A. Chachoua, L. Liebes, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration.

A. Chachoua, J. Sabari, P. Boland, 2021, Lung cancer.

The appearance of cardiac metastasis from squamous cell carcinoma of the lung on F-18 FDG PET/CT and post hoc PET/MRI.

B. Spieler, S. Probst, K. Friedman, 2011, Clinical nuclear medicine.

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma.

D. Peace, H. Hochster, A. Chachoua, 1992, Journal of the National Cancer Institute.

Azygos venous tumor thrombus from renal cell carcinoma detected by F-18 FDG PET/CT.

S. Probst, K. Friedman, A. Chachoua, 2010, Clinical nuclear medicine.

A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting

S. Taneja, F. Muggia, A. Hamilton, 2003, Anti-cancer drugs.

Phase Ib Trial of Granulocyte‐Macrophage Colony‐Stimulating Factor Combined with Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Biologic Activity of Interleukin 1 (IL‐1) Alpha in Patients with Refractory Malignancies

D. Peace, M. Rosenthal, A. Chachoua, 1998, Journal of immunotherapy.

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.

J. Rigas, R. Perez-soler, G. Clark, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin

A. Chachoua, A. Friedman-kien, K. Washenik, 1997, The Lancet.

Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic

R. Cerfolio, H. Pass, M. Zervos, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient with Lung Adenocarcinoma following Treatment with Erlotinib and Osimertinib.

Siraj M. Ali, A. Schrock, A. Chachoua, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.

D. Neuberg, M. Atkins, S. Wadler, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Acquired Immune Deficiency Syndrome

F. Muggia, A. Chachoua, M. Green, 1987 .

Prostatic adenocarcinoma metastatic to the breasts: report of a case with diagnosis by fine needle aspiration biopsy.

G. Newstead, J. Cangiarella, D. Chhieng, 2000, Urology.

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

S. Demaria, S. Adams, J. Goldberg, 2015, The Lancet. Oncology.

An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer

S. Demaria, P. Schiff, S. Formenti, 2013, Cancer Immunology Research.

RICTOR Amplifi cation Defi nes a Novel Subset of Patients with Lung Cancer Who May Benefi t from Treatment with mTORC 1 / 2 Inhibitors

P. Stephens, R. Yelensky, D. Lipson, 2015 .

Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS.

D. Dieterich, C. Worrell, A. Chachoua, 1988, Reviews of infectious diseases.

Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma

H. Pass, A. Wozniak, M. Tsao, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC

A. Chachoua, M. Ballas, 2011, OncoTargets and therapy.

RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.

Sanjay Goel, Kai Wang, Amit Verma, 2015, Cancer discovery.

Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy

R. Camidge, B. Levy, J. Wisnivesky, 2017, Clinical lung cancer.

Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery

D. Kondziolka, B. Cooper, A. Chachoua, 2016, Journal of Neuro-Oncology.

Extension of a secondary adrenal neoplasm into the inferior vena cava

M. Bosniak, A. Chachoua, P. Schlossberg, 1994, Abdominal Radiology.

KRAS mutations predict sensitivity to pemetrexed-based chemotherapy

A. Drilon, D. Lucido, B. Levy, 2013 .

Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.

D. Kondziolka, J. Golfinos, S. Kvint, 2018, Journal of neurosurgery.

Extended Survival in Patients With Non–Small-Cell Lung Cancer–Associated Brain Metastases in the Modern Era

D. Kondziolka, J. Golfinos, V. Velcheti, 2023, Neurosurgery.

Abscopal Responses in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated on a Phase 2 Study of Combined Radiation Therapy and Ipilimumab: Evidence for the In Situ Vaccination Hypothesis of Radiation

S. Demaria, S. Formenti, E. Golden, 2015 .

Monocyte Activation Following Systemic Administration of Granulocyte‐Macrophage Colony‐Stimulating Factor

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma.

F. Muggia, M. Green, A. Chachoua, 1987, Cancer treatment reports.

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone‐refractory prostate carcinoma

S. Taneja, F. Muggia, M. Rosenthal, 2001, Cancer.

Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non-small cell lung cancer.

M E Noz, A Steinfeld, D. McCauley, 1995, Cancer research.

Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases

D. Kondziolka, A. Chachoua, A. Wolf, 2017, Journal of Neuro-Oncology.

Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report.

U. Beller, M. Dugan, A. Chachoua, 1989 .

Reactivation of pulmonary tuberculosis during cancer treatment.

A. Chachoua, P. Gu, Ramon E. A. Jacobs, 2015, International journal of mycobacteriology.

Abstract 244: Abscopal responses in patients with refractory metastatic NSCLC treated with concurrent radiotherapy and CTLA-4 immune checkpoint blockade: evidence for the in situ vaccination hypothesis of radiotherapy

S. Demaria, S. Formenti, E. Golden, 2015 .

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

R. Emerson, A. Heguy, S. Demaria, 2018, Nature Medicine.

CT Scan Screening for Lung Cancer: Risk Factors for Nodules and Malignancy in a High-Risk Urban Cohort

Georgeann McGuinness, David Naidich, Judith D. Goldberg, 2012, PloS one.

Phase I study of the combination of alpha-2 interferon and cisplatinum.

H. Hochster, A. Chachoua, J. Speyer, 1989, Journal of biological response modifiers.

Plasma osteopontin and the prognosis of pleural mesothelioma.

H. Pass, C. Goparaju, A. Wozniak, 2013 .

Phase IB study of low‐dose intraperitoneal recombinant interleukin‐2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report

U. Beller, M. Dugan, A. Chachoua, 1990, Gynecologic oncology.

1018P Phase I/II trial of rigosertib and nivolumab for KRAS mutated non-small cell lung cancer (NSCLC) patients

F. Hirsch, R. Samstein, T. Marron, 2022, Annals of Oncology.

335 RICTOR amplification as a novel molecular target for the treatment of lung cancer

B. Halmos, R. Perez-soler, A. Verma, 2014 .

Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M-Mutant Leptomeningeal Lung Adenocarcinoma.

D. Kondziolka, R. Jain, M. Snuderl, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

D. Neuberg, M. Atkins, S. Wadler, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS)

H. Hochster, A. Chachoua, J. Speyer, 1997 .